Literature DB >> 20714747

Choroidal neovascularization in a patient with blunt trauma-caused traumatic retinopathy without choroidal rupture.

Mitsuo Takahashi1, Satoshi Kinoshita, Wataru Saito, Manabu Kase, Susumu Ishida.   

Abstract

PURPOSE: To report a case of choroidal neovascularization (CNV) following blunt trauma without choroidal rupture, with past history of central serous chorioretinopathy (CSC).
METHODS: A 43-year-old man with a nonperforating injury caused by a baseball that hit his right eye exhibited traumatic retinopathy. The damage was localized to the outer layer of the retina at the macula and there was no choroidal rupture. Five years prior to the accident, the patient suffered from a CSC attack with retinal pigment epithelium detachment. Two weeks after the blunt trauma, fundus examination revealed CNV extending into the subfoveal space, which led to an abrupt development of retinal hemorrhage and serous retinal detachment at the macula. Intravitreal injection of bevacizumab led to the resolution of retinal detachment 15 days later, with complete absorption of retinal hemorrhage 41 days later. Fluorescein angiography performed 2 months later revealed hyperfluorescent points with no leakage.
CONCLUSION: CNV following blunt trauma in this case occurred in traumatic retinopathy, with the damage localized in the outer layer of the retina. This suggests that the retinal pigment epithelium-Bruch's membrane complex developed susceptibility to anteroposterior forces, which is subsequent to the spontaneous healing of CSC. Bevacizumab treatment also reduced exudation from CNV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714747     DOI: 10.1007/s00417-010-1472-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

Review 1.  Choroidal neovascularization: a wound healing perspective.

Authors:  David Kent; Carl Sheridan
Journal:  Mol Vis       Date:  2003-12-22       Impact factor: 2.367

Review 2.  Choroidal neovascularization.

Authors:  Hans E Grossniklaus; W Richard Green
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

3.  Histopathology of commotio retinae.

Authors:  A M Mansour; W R Green; C Hogge
Journal:  Retina       Date:  1992       Impact factor: 4.256

4.  Photodynamic therapy of a posttraumatic choroidal neovascular membrane.

Authors:  Hitendra B Mehta; Mahesh P Shanmugam
Journal:  Indian J Ophthalmol       Date:  2005-06       Impact factor: 1.848

5.  Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture.

Authors:  Christine Shortsleeve Ament; David N Zacks; Anne Marie Lane; Magdalena Krzystolik; Donald J D'Amico; Shizuo Mukai; Lucy H Young; John Loewenstein; Jorge Arroyo; Joan W Miller
Journal:  Arch Ophthalmol       Date:  2006-07

6.  Alterations of retinal pigment epithelium in central serous chorioretinopathy.

Authors:  Yasuhiko Hirami; Akitaka Tsujikawa; Manabu Sasahara; Norimoto Gotoh; Hiroshi Tamura; Atsushi Otani; Michiko Mandai; Nagahisa Yoshimura
Journal:  Clin Exp Ophthalmol       Date:  2007-04       Impact factor: 4.207

7.  Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

Authors:  Subrata Mandal; Satpal Garg; Pradeep Venkatesh; Charu Mithal; Rajpal Vohra; Abhas Mehrotra
Journal:  Arch Ophthalmol       Date:  2007-11

8.  Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture.

Authors:  Feng Liang; Nathalie Puche; Gisèle Soubrane; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-26       Impact factor: 3.117

  8 in total
  1 in total

1.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  BMC Ophthalmol       Date:  2019-11-26       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.